{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T19:48:41Z","timestamp":1720122521611},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Medical Informatics"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ijmedinf.2023.105305","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T12:43:48Z","timestamp":1701434628000},"page":"105305","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Electronic-PRO Measures for adverse events Of Treatment In ONcology (E-PROMOTION)"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"http:\/\/orcid.org\/0000-0002-3132-6017","authenticated-orcid":false,"given":"Anindita","family":"Pradhan","sequence":"first","affiliation":[]},{"given":"Pradeep","family":"Dwivedi","sequence":"additional","affiliation":[]},{"given":"Puneet","family":"Pareek","sequence":"additional","affiliation":[]},{"given":"Sumit","family":"Kalra","sequence":"additional","affiliation":[]},{"given":"Surjit","family":"Singh","sequence":"additional","affiliation":[]},{"given":"Shoban Babu","family":"Varthya","sequence":"additional","affiliation":[]},{"given":"Akhil Dhanesh","family":"Goel","sequence":"additional","affiliation":[]},{"given":"Muhammad Aaqib","family":"Shamim","sequence":"additional","affiliation":[]},{"given":"Jeevan Ram","family":"Vishnoi","sequence":"additional","affiliation":[]},{"given":"Prem Prakash","family":"Sharma","sequence":"additional","affiliation":[]},{"given":"Abhilipsa","family":"Pradhan","sequence":"additional","affiliation":[]},{"given":"Sneha","family":"Ambwani","sequence":"additional","affiliation":[]},{"given":"Sanjeev","family":"Misra","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.ijmedinf.2023.105305_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijmedinf.2023.105305_b0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/0971-5851.177015","article-title":"Chemotherapy-induced adverse drug reactions in oncology patients: a prospective observational survey","volume":"37","author":"Chopra","year":"2016","journal-title":"Indian J. Med. Paediatr. Oncol."},{"key":"10.1016\/j.ijmedinf.2023.105305_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184360","article-title":"Incidence and severity of self-reported chemotherapy side effects in routine care: a prospective cohort study","volume":"12","author":"Pearce","year":"2017","journal-title":"PLoS One"},{"issue":"61","key":"10.1016\/j.ijmedinf.2023.105305_b0020","first-page":"53","article-title":"Prevalence and predictors of patients reporting adverse drug reactions to health care providers during oral targeted cancer treatment","volume":"2021","author":"Monestime","year":"2003","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.ijmedinf.2023.105305_b0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/bcp.13098","article-title":"The value of patient reporting to the pharmacovigilance system: a systematic review","volume":"83","author":"In\u00e1cio","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijmedinf.2023.105305_b0030","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.8_suppl.45","article-title":"Improving oral chemotherapy adverse event reporting: listening to pediatric oncology patients and parents","volume":"35","author":"Zerillo","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijmedinf.2023.105305_b0035","unstructured":"Hospital for Special Surgery: Patient-Reported Outcome Measures (PROMs), Accessed: June 29, 2022, https:\/\/www.hss.edu\/proms.asp."},{"key":"10.1016\/j.ijmedinf.2023.105305_b0040","unstructured":"National Cancer Institute: Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), 2022, Accessed: June 29, 2022, https:\/\/healthcaredelivery.cancer.gov\/pro-ctcae\/, 2020."},{"key":"10.1016\/j.ijmedinf.2023.105305_b0045","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the National Cancer Institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"106","author":"Basch","year":"2014","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.ijmedinf.2023.105305_b0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s41687-023-00544-4","article-title":"Patient and clinician-reported experiences of using electronic patient reported outcome measures (ePROMs) as part of routine cancer care","volume":"7","author":"Payne","year":"2023","journal-title":"J. Patient Rep. Outcomes."},{"key":"10.1016\/j.ijmedinf.2023.105305_b0055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jgo.2018.05.016","article-title":"Clinician-observed and patient-reported toxicities and their association with poor tolerance to therapy in older patients with head and neck or lung cancer treated with curative radiotherapy","volume":"10","author":"Moon","year":"2019","journal-title":"J. Geriatr. Oncol."},{"key":"10.1016\/j.ijmedinf.2023.105305_b0060","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1634\/theoncologist.2018-0332","article-title":"Feasibility assessment of using the complete patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) item library","volume":"24","author":"Shepshelovich","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.ijmedinf.2023.105305_b0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/tbj.13204","article-title":"Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients-Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology C","volume":"25","author":"Pappot","year":"2019","journal-title":"Breast J."},{"key":"10.1016\/j.ijmedinf.2023.105305_b0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40487-018-0065-7","article-title":"Routine surveillance of chemotherapy toxicities in cancer patients using the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"6","author":"Wang","year":"2018","journal-title":"Oncol. Ther."},{"key":"10.1016\/j.ijmedinf.2023.105305_b0075","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1177\/0962280215588241","article-title":"Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable","volume":"25","author":"Whitehead","year":"2016","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.ijmedinf.2023.105305_b0080","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","article-title":"Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation","volume":"8","author":"Wild","year":"2005","journal-title":"Value Health"},{"key":"10.1016\/j.ijmedinf.2023.105305_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2023.105214","article-title":"Mobile health interventions for cancer patient education: a scoping review","volume":"179","author":"Samadbeik","year":"2023","journal-title":"Int. J. Med. Inf."},{"issue":"17\u201321","key":"10.1016\/j.ijmedinf.2023.105305_b0090","article-title":"Clinical relevance of routine monitoring of patient-reported outcomes versus clinician-reported outcomes in oncology","volume":"33","author":"Fiteni","year":"2019","journal-title":"In Vivo"},{"key":"10.1016\/j.ijmedinf.2023.105305_b0095","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1200\/OP.20.00118","article-title":"Electronic patient reporting of adverse events and quality of life: a prospective feasibility study in general oncology","volume":"17","author":"Kennedy","year":"2021","journal-title":"JCO Oncol. Pract."},{"key":"10.1016\/j.ijmedinf.2023.105305_b0100","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s00520-023-08068-9","article-title":"Use of patient-reported outcome measures for oncology drugs receiving accelerated approval","volume":"31","author":"Moore","year":"2023","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijmedinf.2023.105305_b0105","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/0284186X.2018.1563713","article-title":"Comparing the patients\u2019 subjective experiences of acute side effects during radiotherapy for head and neck cancer with four different patient-reported outcomes questionnaires","volume":"58","author":"Holl\u00e4nder-Mieritz","year":"2019","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ijmedinf.2023.105305_b0110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s41687-023-00640-5","article-title":"The iBLAD study: patient-reported outcomes in bladder cancer during oncological treatment: a multicenter national randomized controlled trial","volume":"7","author":"Taarnh\u00f8j","year":"2023","journal-title":"J. Patient Rep. Outcomes"},{"key":"10.1016\/j.ijmedinf.2023.105305_b0115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00520-023-07779-3","article-title":"Efficacy of the PRO-CTCAE mobile application for improving patient participation in symptom management during cancer treatment: a randomized controlled trial","volume":"31","author":"Lee","year":"2023","journal-title":"Support Care Cancer"}],"container-title":["International Journal of Medical Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386505623003234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386505623003234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T06:08:51Z","timestamp":1704348531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386505623003234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":23,"alternative-id":["S1386505623003234"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmedinf.2023.105305","relation":{},"ISSN":["1386-5056"],"issn-type":[{"value":"1386-5056","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electronic-PRO Measures for adverse events Of Treatment In ONcology (E-PROMOTION)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Medical Informatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmedinf.2023.105305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105305"}}